Qianqian Cheng
Bengbu, 233004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
High expression of MPP6 predicts poor patient prognosis and promotes malignant biological behaviors of hepatocellular carcinoma cells
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: February 03, 2026
Comprehensive analysis of PHF5A as a potential prognostic biomarker and therapeutic target across cancers and in hepatocellular carcinoma.
Journal: BMC cancer
Published: May 03, 2024
Construction and validation of a prognostic and therapeutic cuproptosis- and immune-related gene signature in hepatocellular carcinoma.
Journal: Translational cancer research
Published: November 26, 2023
Development and validation of novel immune-inflammation-based clinical predictive nomograms in HER2-negative advanced gastric cancer.
Journal: Frontiers in oncology
Published: March 15, 2023
Elevated MPP6 expression correlates with an unfavorable prognosis, angiogenesis and immune evasion in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: February 25, 2023
Research progress and therapeutic prospect of PHF5A acting as a new target for malignant tumors.
Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: December 29, 2022
Real-World Outcome and Prognostic Factors Among HER2-Positive Metastatic Breast Cancer Patients Receiving Pyrotinib-Based Therapy: A Multicenter Retrospective Analysis.
Journal: Breast cancer (Dove Medical Press)
Published: August 18, 2022
Methylselenocysteine Potentiates Etoposide-Induced Cytotoxicity by Enhancing Gap Junction Activity.
Journal: Biological & pharmaceutical bulletin
Published: April 04, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026